ÃֽŠ°Ë»çÇ׸ñ°ú °Ë»çÆÐ³ÎÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
| °Ë»çÄÚµå | °Ë»ç¸í | °Ëü | °Ë»çÀÏ | ¼Ò¿äÀÏ | º¸ÇèÄÚµå |
|---|---|---|---|---|---|
| A6629 | TGFBI mutation (Sequencing) | ±¸°Á¡¸·¼¼Æ÷ | ¿ù-±Ý | 3ÀÏ | C5806336Z |
| A6629 | TGFBI mutation (Sequencing) | WB(EDTA) | ¿ù-±Ý | 3ÀÏ | C5806336Z |
| D6999 | TGFBI R124H Avellino corneal dystrophy (PCR) | ±¸°Á¡¸·¼¼Æ÷ | ¿ù-Åä | 1ÀÏ | C5801096Z |
| D6999 | TGFBI R124H Avellino corneal dystrophy (PCR) | WB(EDTA) | ¿ù-Åä | 1ÀÏ | C5801096Z |
| H0766 | TGFBR1 gene, mutation (Loeys-Dietz syndrome) | WB(EDTA) | ¿ù-¸ñ | 5ÁÖ | C5807606Z |
| H0767 | TGFBR2 gene, mutation (Loeys-Dietz syndrome) | WB(EDTA) | ¿ù-¸ñ | 5ÁÖ | C5808706Z |
| B5352 | Theophylline | Serum | ¿ù-Åä | 1ÀÏ | D5333430Z |
| H0678 | THRB gene (Des)[Sequencing] | WB(EDTA) | ¿ù-¸ñ | 3ÁÖ | C5807616Z |
| A0530 | Thrombin AT-III Com. | Sod. Citrate | È,±Ý | 15ÀÏ | |
| B1560 | Thrombin time | Sod. Citrate | ¿ù,¼ö,±Ý | 1ÀÏ | D1006000Z |
| IHC2005 | Thyroid papillary carcinoma | Paraffin Block | ¿ù-±Ý | 3ÀÏ | C5673006Z*3 |
| A0718 | Thyroid stimulating Ab | Serum | ¿ù,¼ö,±Ý | 2ÀÏ | D3214010Z |
| B2870 | TIBC | Serum | ¿ù-Åä(¾ß°£) | 1ÀÏ | D0521040Z |
| A6554 | Tissue Mineral Analysis | TMA | ¿ù-¸ñ | 10ÀÏ | |
| C6817 | TKI ¾àÁ¦³»¼º(major BCR/ABL1) [Sequencing] | WB(EDTA) | ¿ù-¸ñ | 12ÀÏ | C5838016Z |
| C6817 | TKI ¾àÁ¦³»¼º(major BCR/ABL1) [Sequencing] | Bone marrow | ¿ù-¸ñ | 12ÀÏ | C5838016Z |
| C6048 | TLX3 (5q35) | Bone marrow | ¿ù-¸ñ | 2ÁÖ | C5841106Z |
| C6048 | TLX3 (5q35) | Cell pellet | ¿ù-¸ñ | 2ÁÖ | C5841106Z |
| C6048 | TLX3 (5q35) | other | ¿ù-¸ñ | 2ÁÖ | C5841106Z |
| D1668 | TM (TPO)-Ab | Serum | ¿ù-Åä(¾ß°£) | 1ÀÏ | D3212040Z |